Pharmacologic and pharmacokinetic assessment of anti-TGFbeta2 aptamers in rabbit plasma and aqueous humor. (Q54167016)

25 May 2018

title

Pharmacologic and pharmacokinetic assessment of anti-TGFbeta2 aptamers in rabbit plasma and aqueous humor. (English)

1 reference

25 May 2018

1 reference

Thomas G McCauley

1

1 reference

25 May 2018

Jeffrey C Kurz

2

1 reference

25 May 2018

Patricia G Merlino

3

1 reference

25 May 2018

Scott D Lewis

4

1 reference

25 May 2018

Madaline Gilbert

5

1 reference

25 May 2018

David M Epstein

6

1 reference

25 May 2018

H Nicholas Marsh

7

1 reference

25 May 2018

publication date

19 January 2006

1 reference

25 May 2018

published in

Pharmaceutical Research

1 reference

25 May 2018

volume

23

1 reference

25 May 2018

issue

2

1 reference

25 May 2018

page(s)

303-311

1 reference

25 May 2018

Late onset of sequential multifocal bleb leaks after glaucoma filtration surgery with 5-fluorouracil and mitomycin C.

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11095-005-9305-2

Adjunctive mitomycin C in primary trabeculectomy in phakic eyes

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11095-005-9305-2

Anti-L-selectin aptamers: binding characteristics, pharmacokinetic parameters, and activity against an intravascular target in vivo

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11095-005-9305-2

Higher concentration of transforming growth factor-beta in aqueous humor of glaucomatous eyes and diabetic eyes.

21 January 2018

1 reference

12 December 2020

Evaluation of anti-TGF-beta2 antibody as a new postoperative anti-scarring agent in glaucoma surgery.

1 reference

12 December 2020

Pharmacokinetics and biodistribution of novel aptamer compositions

1 reference

12 December 2020

Comparison of visual field progression in patients with normal pressure glaucoma between eyes with and without visual field loss that threatens fixation

1 reference

12 December 2020

Comparison of the biological actions of TGF beta-1 and TGF beta-2: differential activity in endothelial cells

1 reference

12 December 2020

Novel antisense oligonucleotides targeting TGF-beta inhibit in vivo scarring and improve surgical outcome.

1 reference

12 December 2020

Transforming growth factor-beta1, -beta2, and -beta3 in vivo: effects on normal and mitomycin C-modulated conjunctival scarring

1 reference

12 December 2020

Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase

1 reference

12 December 2020

Direct in vitro selection of a 2'-O-methyl aptamer to VEGF.

1 reference

12 December 2020

Efficacy and safety of mitomycin-C in primary trabeculectomy: five-year follow-up

1 reference

12 December 2020

Human anti-transforming growth factor-beta2 antibody: a new glaucoma anti-scarring agent

1 reference

12 December 2020

Kinetic Characterization of Ribonuclease-Resistant 2′-Modified Hammerhead Ribozymes

1 reference

12 December 2020

Identification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor.

1 reference

12 December 2020

Surgical strategies in patients with cataract and glaucoma

1 reference

12 December 2020

10.1007/S11095-005-9305-2

Identifiers

DOI

1 reference

25 May 2018

1 reference

25 May 2018